USP forum goes gratis
This article was originally published in The Tan Sheet
Executive Summary
The Pharmacopeial Forum becomes a free online resource starting in January, the U.S. Pharmacopeia says Sept. 8, allowing "greater participation in the standards-setting process for drugs, excipients and dietary supplements." PF is the nonprofit group's journal for public comment, giving manufacturers, regulators and other stakeholders a chance to provide feedback on proposed standards before they become official in USP's National Formulary. The May-June issue of PF sought comments on standards for bacopa monnieri, garcinia gummi-gutta and other Indian botanicals used in supplements and traditional medicines (1"The Tan Sheet" May 10, 2010, In Brief)
You may also be interested in...
USP standardizes Indian botanicals
The U.S. and Indian pharmacopeias jointly propose standards for the identity, strength, quality and purity of four botanical articles in multiple forms used in U.S. dietary supplements and Indian traditional medicines. Monographs for the botanicals bacopa monnieri, garcinia gummi-gutta, garcinia indica and plectranthus barbatus are in the May-June issue of Pharmacopeial Forum, USP said May 5. The Rockville, Md.-based organization seeks comments on the standards before they are finalized. USP will publish official monograph standards for the botanicals ashwagandha root, andrograpahis aerial parts and boswellia serrata in February 2011, USP said
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.